CHENGDU, China, May 12, 2011 /PRNewswire-Asia-FirstCall/ —
Tianyin Pharmaceutical Co., Inc. (NYSE Amex:
TPI), a pharmaceutical company that specializes in patented
biopharmaceutical medicine, modernized traditional Chinese
medicine, branded generics and other pharmaceuticals, today
announced that the earnings conference call for the third quarter
of fiscal year 2011 ending March 31, 2011 to be held at 9:00 a.m.
ET on Tuesday, May 17, 2011.
Interested parties may access the call by dialing
+1-877-941-1427 (U.S.), 1-480-629-9664 (International)
The conference ID is 4441371. It is advisable to dial in
approximately 5 minutes prior to the start of the call.
A replay will be available by calling +1-877-870-5176 (U.S.),
1-858-384-5517 (International), from 05/17/2011 at 12:00 Noon ET
till 05/31/2011 at 11:59 pm ET.
Replay Pin Number: 4441371
This call is being web cast by ViaVid Broadcasting and can be
accessed at ViaVid’s website at the following link: http://viavid.net/dce.aspx?sid=0000869E
About Tianyin PharmaceuticalHeadquartered at Chengdu, China,
TPI is a pharmaceutical company that specializes in the
development, manufacturing, marketing and sales of patented
biopharmaceutical, modernized traditional Chinese medicines,
branded generics and other pharmaceuticals. TPI currently
manufactures a comprehensive portfolio of 56 products, 23 of which
are listed in the highly selective national medicine reimbursement
list, 7 are included in the essential drug list of China. TPI’s
pipeline targets various high incidence healthcare indications. TPI
has an extensive nationwide distribution network with a sales force
of 730 sales representatives out of totaled 1,365
employees.
For more information about TPI, please visit: http://www.tianyinpharma.com</
‘/>”/>
